UN agency authorizes second vaccine against dengue amid outbreaks in the Americas
The World Health Organization has authorized a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease that has already sparked numerous outbreaks across the Americas this year
By Ap News
Published - May 15, 2024, 07:11 AM ET
Last Updated - May 27, 2024, 12:56 AM EDT
GENEVA (AP) —
The World Health Organization on Wednesday authorized a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease that has already sparked numerous outbreaks across the Americas this year.
In a statement on Wednesday, the U.N. health agency said it approved the dengue vaccine made by the Japanese pharmaceutical Takeda, recommending its use in children between six to 16 years old living in regions with high rates of dengue. The two-dose vaccine protects against the four types of dengue.
Takeda’s dengue vaccine, known as Qdenga, was previously given the nod by the European Medicines Agency in 2022.
